Novo Nordisk to present new data highlighting innovative rare blood disorders pipeline at ASH 2024
Press Releases
Novo Nordisk  
December 3, 2024

Novo Nordisk to present new data highlighting innovative rare blood disorders pipeline at ASH 2024

Clinical data include analyses of novel, investigational therapies with the potential to help address unmet needs in sickle cell disease and hemophiliaNew data from the HIBISCUS phase 2 trial evaluating

logo salamanca press

Salamanca Press

Local & Social